Reuters logo
15 天前
BRIEF-Karyopharm Therapeutics Q2 loss per share $0.64
2017年8月8日 / 上午11点16分 / 15 天前

BRIEF-Karyopharm Therapeutics Q2 loss per share $0.64

Aug 8 (Reuters) - Karyopharm Therapeutics Inc

* Karyopharm reports second quarter 2017 financial results and highlights recent progress

* Q2 loss per share $0.64

* Q2 earnings per share view $-0.65 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below